Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 323.00
Bid: 328.00
Ask: 331.50
Change: -5.50 (-1.67%)
Spread: 3.50 (1.067%)
Open: 323.00
High: 323.00
Low: 323.00
Prev. Close: 328.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

1 Jul 2019 10:01

RNS Number : 0052E
Oxford Biomedica PLC
01 July 2019
 

For Immediate Release

1 July 2019

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

159,894

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

128,737

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

31,157

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

325,731

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

54,856

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

270,875

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

117,010

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

14,664

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

102,346

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

263,724

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

26,500

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

237,224

 

 

 

Name of contact:

Stuart Paynter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRUGUUUMUPBUBG
Date   Source Headline
16th Dec 20143:50 pmRNSDirector PDMR Shareholding
16th Dec 20143:50 pmRNSNotification Of Major Interest In Shares
1st Dec 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
28th Nov 20147:00 amRNSTotal Voting Rights
26th Nov 20147:00 amRNSDirector Dealings
3rd Nov 20147:00 amRNSInterim Management Statement
31st Oct 20147:00 amRNSTotal Voting Rights
17th Oct 20149:27 amRNSDirector's Interest in Share Options
17th Oct 20149:10 amRNSHolding(s) in Company
16th Oct 20144:52 pmRNSDirectorate Change
15th Oct 20145:05 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
13th Oct 20147:00 amRNSOxford BioMedica Acquires Windrush Court Office
10th Oct 20147:41 amRNSAdditional Listing
10th Oct 20147:00 amRNSSecond major agreement with Novartis
28th Aug 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSPaul Blake Appointed as Chief Development Officer
7th Aug 20147:00 amRNSNotice of Results
25th Jul 20149:48 amRNSBlock listing Application
1st Jul 201410:55 amRNSOxford BioMedica plc Director's Share Purchase
30th Jun 20147:00 amRNSTotal Voting Rights Update
23rd Jun 20147:00 amRNSDirectors' Interest in Share Options
20th Jun 20142:38 pmRNSPiper Jaffray GenomeRx Symposium in New York
19th Jun 20149:50 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:01 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:00 amRNSGRANT OF AWARDS
18th Jun 201411:30 amRNSLoan Repayment in Full
18th Jun 20149:36 amRNSHolding(s) in Company
18th Jun 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jun 201412:29 pmRNSRESULT OF GENERAL MEETING AND DIRECTORS DEALING
16th Jun 20147:00 amRNSResults of firm fundraising and open offer
3rd Jun 201412:34 pmRNSResult of AGM
29th May 20144:52 pmRNSNotice of posting of prospectus
29th May 20147:00 amRNSFundraising and Open Offer
22nd May 20149:22 amRNSDirector Declaration
13th May 20147:00 amRNSInterim Management Statement
2nd May 20144:57 pmRNS2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30th Apr 20147:00 amRNS£2.2 Million Grant Received from TSB
29th Apr 20147:00 amRNSOxford BioMedica provides update on RetinoStat®
10th Apr 20147:00 amRNSFinal Results
7th Apr 20147:00 amRNSOXB completes patient recruitment into RetinoStat
21st Mar 20147:00 amRNSOXB Present at Regen Med Investor Day
17th Feb 20147:00 amRNSOxford BioMedica and Sanofi Amend Terms for Ocular
17th Jan 20144:40 pmRNSSecond Price Monitoring Extn
17th Jan 20144:35 pmRNSPrice Monitoring Extension
10th Jan 20147:00 amRNSPublication of ProSavin Phase I/II Study
9th Jan 201412:19 pmRNSOxford BioMedica to Present at Biotech Showcase
6th Jan 201410:28 amRNSOxford Biomedica PLC - General Meeting
18th Dec 20137:00 amRNSOXB option agreement with GSK
11th Dec 20137:00 amRNSCIRCULAR & GENERAL MEETING NOTIFICATION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.